LOANS for Biomedical Research Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 7539.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. FITZPATRICK, as printed in the Congressional Record (Vol. 170, No. 39, March 5, 2024, Page H822):
  Article 1, Section 8, Clause 18 The single subject of this legislation is: To require the Secretary of the Treasury to guarantee BioBonds in order to provide funding for loans to eligible biomedical companies and universities to carry out clinical trials approved by the Food and Drug Administration, and for other purposes.
  Source: Congress.gov, Congressional Record March 5, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  324 characters

  Congress.gov bill record

  H.R. 7539, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/7539

  Record last updated by Congress.gov

  August 21, 2024

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  bbaf4ba58e1fc81824de00163176af74f3d880a000abc919250fa3273e5b0833

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of August 21, 2024). Not every bill gets one.

From the Congress.gov bill record for H.R. 7539, last updated August 21, 2024. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.